Current Therapy of Type 2 Diabetes Mellitus using a Sample of SulfonylureaG — Prolonged Releasing Gliclazide Produced by Pharmak, Ltd (Kyiv, Ukraine)
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 2, Issue 66
Abstract
The paper describes the efficacy of sulfonylurea derivative — domestic medication Dіaglizide MR (Farmak, Ltd) in the treatment of type 2 diabetes mellitus. The efficacy and safety of the agent confirmed in scientific studies allow recommend it for the treatment of type 2 diabetes mellitus.
Authors and Affiliations
O. Yu. Mykhailenko
Functional state of the pituitary-thyroid system in children with allergic dermatosis
Background. Approximately 10 % of the pediatric population suffers from atopic dermatitis, and this disease is most common skin allergic pathology. The influence of thyroid hormones on the development of atopy is known....
Carbohydrate Metabolism Disorders in Patients with Chronic Pancreatitis
This article deals with dependence of the carbohydrate metabolism disorders on the duration of disease in patients with non-destructive chronic pancreatitis. Patients with a disease duration of up to three years we mainl...
Anticoagulation Therapy with Bemiparin in Combination Treatment of Patients with Diabetic Peripheral Neuropathy and Latent Ischemia of Lower Limb Tissues
It is known that diabetic peripheral neuropathy as well as microangiopathy increases risk of diabetic foot syndrome development even with preserved patency of main arteries of the lower limbs. In this paper we examined t...
Central Diabetes Insipidus
The lecture presents modern data on epidemiology, etiology, pathogenesis, diagnosis and treatment of central diabetes insipidus.
Male factor of sterility: algorithm of laboratory diagnosis of the causes (part 2)
Previously, the topics of laboratory diagnosis were covered: assessment of the male androgenic status: what to choose — total or free testosterone; or use an estimated indicator — free testosterone index; what is importa...